JPRN-jRCT2080224808已完成1 期
Phase 1 trial of adrenomedullin; Single-dose administration study
niversity of Miyazaki0 个研究点目标入组 24 人开始时间: 2019年7月29日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 65age old（—）
- 性别
- Male
入选标准
- •healthy male
排除标准
- •history of malignancy and/or myocardial infarction
- •systolic blood pressure under 100 mmHg
- •pulse rate under 45 bpm
- •body weight over 90 kg
研究者
相似试验
已完成
1 期
Multiple-dose administration study of adrenomedulliJPRN-jRCT2080224807niversity of MIyazaki12
已完成
1 期
A pharmacokinetic study of novel formulations of ISC 17536 in healthy male adultsCTRI/2020/09/028094Glenmark Pharmaceuticals Ltd108
进行中（未招募）
1 期
Clinical trial of chemotherapy combination cisplatin + fluorouracil with the novel targeted agent afatinib in patients with inoperable gastric cancerInoperable gastric and gastroesophageal junction cancerMedDRA version: 15.0Level: LLTClassification code 10017760Term: Gastric cancer NOSSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2011-006198-25-GRHellenic Cooperative Oncology Group55
已完成
不适用
A phase 1 clinical trial to investigate the absorption, metabolism and excretion of JBPOS0101 after oral administration of JBPOS0101 600 mg and 14C-labeled JBPOS0101 at a microdose in healthy adultsDiseases of the nervous systemKCT0008718Bio-Pharm Solutions6
进行中（未招募）
1 期
A study to evaluate the effect of highly reduced kidney function on the processing of fenebrutinib in the bodyISRCTN41455091Genentech, Inc16